Browsing: Disease Area > Viral
Take a look behind the scenes of a recent Future Virology review entitled ‘Antiviral therapeutic approaches for human rhinovirus infections’ as we ask author Peter Barlow about antivirals, antibodies and the host response.
Take a look at how portable, long-read nanopore sequencing can be applied to the study of hepatitis B virus.
A recent study has demonstrated a significant decrease in cases of human papilloma virus infection in England since the introduction of a bivalent vaccine in 2008.
Take a look behind the scenes of a recent Future Virology review as we ask author Geoffrey Dusheiko about the challenges facing hepatitis B and what the future may hold in terms of functional cure and new research directions.
At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
New research indicates that false negative RIAT results could delay antiviral therapy for half of patients admitted to intensive care units.
Research presented at ASM Microbe has revealed that Treg cells may be protecting babies from contracting HIV from their mothers in utero.
In line with our focus this month on emerging technologies, we spoke to Eugene Koonin, Senior Investigator at the National Center for Biotechnology Information, about metagenomics and how it can be used to understand more about the global virome.